Key highlights from the Type C FDA meeting include: FDA confirms the approach that the proposed primary endpoint of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results